NEW YORK – After studying how some 12,000 lung cancer patients are receiving care across community practices, McKesson and its collaborators are hoping to establish best practices that can improve access to molecularly informed care.
McKesson-led Consortium to Establish Best Practices for Lung Cancer Molecular Testing, Treatment
Premium
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.